AbCellera Biologics Inc.ABCLNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+20.1%
5Y CAGR+44.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+20.1%/yr
vs +107.6%/yr prior
5Y CAGR
+44.8%/yr
Recent deceleration
Acceleration
-87.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $186.83M | +11.7% |
| 2024 | $167.26M | -4.8% |
| 2023 | $175.66M | +62.8% |
| 2022 | $107.88M | +73.8% |
| 2021 | $62.06M | +111.1% |
| 2020 | $29.39M | +190.6% |
| 2019 | $10.11M | +74.3% |
| 2018 | $5.80M | - |